1 | BBIO | BridgeBio Pharma, Inc. | 2.15% |
2 | CRSP | CRISPR Therapeutics AG | 2.13% |
3 | IONS | Ionis Pharmaceuticals, Inc. | 2.11% |
4 | INSM | Insmed Incorporated | 1.98% |
5 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.97% |
7 | MIRM | Mirum Pharmaceuticals, Inc. | 1.95% |
8 | EXEL | Exelixis, Inc. | 1.95% |
9 | KNSA | Kiniksa Pharmaceuticals International, plc | 1.94% |
10 | INCY | Incyte Corporation | 1.93% |
11 | ACAD | ACADIA Pharmaceuticals Inc. | 1.93% |
12 | KRYS | Krystal Biotech, Inc. | 1.92% |
13 | TGTX | TG Therapeutics, Inc. | 1.92% |
14 | NBIX | Neurocrine Biosciences, Inc. | 1.91% |
15 | TVTX | Travere Therapeutics, Inc. | 1.91% |
16 | ASND | Ascendis Pharma A/S | 1.91% |
17 | BNTX | BioNTech SE | 1.91% |
18 | ROIV | Roivant Sciences Ltd. | 1.91% |
19 | TBPH | Theravance Biopharma, Inc. | 1.91% |
20 | LGND | Ligand Pharmaceuticals Incorporated | 1.91% |
21 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.90% |
22 | MRNA | Moderna, Inc. | 1.90% |
23 | REGN | Regeneron Pharmaceuticals, Inc. | 1.88% |
24 | UTHR | United Therapeutics Corporation | 1.87% |
25 | ARDX | Ardelyx, Inc. | 1.87% |
View BBP holdings |